UBS Group’s Veradermics Inc MANE Stock Holding History

UBS Group’s Portfolio MANE Stock Details MANE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.5M	Buy	670,727 +323,652	+93%	+$30.3M	0.01%	1273
2026 Q1	$21.9M	Buy	+347,075	New	+$17.5M	﹤0.01%	2493

Other funds holding MANE

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

UBS Group's MANE Position: Q2 2026 in Review

UBS Group increased its Veradermics Inc (MANE) stake by 93% in Q2 2026, buying an estimated $30.3M and bringing the position to 670,727 shares worth $82.5M. The position accounts for 0.01% of the portfolio, ranked #1273.

UBS Group first reported a position in MANE in Q1 2026 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

UBS Group held 670,727 shares of Veradermics Inc worth $82.5M as of Q2 2026.
UBS Group bought 323,652 Veradermics Inc shares in Q2 2026, an estimated $30.3M.
Veradermics Inc made up 0.01% of UBS Group's portfolio in Q2 2026, its #1273 holding.
UBS Group first reported a position in Veradermics Inc in Q1 2026 and has held it in 2 quarters since.
164 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.